These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 38113889)

  • 1. Accurate modeling of peptide-MHC structures with AlphaFold.
    Mikhaylov V; Brambley CA; Keller GLJ; Arbuiso AG; Weiss LI; Baker BM; Levine AJ
    Structure; 2024 Feb; 32(2):228-241.e4. PubMed ID: 38113889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate modeling of peptide-MHC structures with AlphaFold.
    Mikhaylov V; Levine AJ
    bioRxiv; 2023 Mar; ():. PubMed ID: 36945436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules.
    Appella E; Padlan EA; Hunt DF
    EXS; 1995; 73():105-19. PubMed ID: 7579970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide binding by class I and class II MHC molecules.
    Batalia MA; Collins EJ
    Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Static energy analysis of MHC class I and class II peptide-binding affinity.
    Davies MN; Flower DR
    Methods Mol Biol; 2007; 409():309-20. PubMed ID: 18450011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptides bound to major histocompatibility complex molecules.
    Maffei A; Harris PE
    Peptides; 1998; 19(1):179-98. PubMed ID: 9437752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Neoantigen Discovery Using Large-Scale Immunopeptidomes and Composite Modeling of MHC Peptide Presentation.
    Pyke RM; Mellacheruvu D; Dea S; Abbott C; Zhang SV; Phillips NA; Harris J; Bartha G; Desai S; McClory R; West J; Snyder MP; Chen R; Boyle SM
    Mol Cell Proteomics; 2023 Apr; 22(4):100506. PubMed ID: 36796642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biochemistry and cell biology of antigen processing and presentation.
    Germain RN; Margulies DH
    Annu Rev Immunol; 1993; 11():403-50. PubMed ID: 8476568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico prediction of peptide-MHC binding affinity using SVRMHC.
    Liu W; Wan J; Meng X; Flower DR; Li T
    Methods Mol Biol; 2007; 409():283-91. PubMed ID: 18450008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
    Zhao W; Sher X
    PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the structure of bound peptide ligands to major histocompatibility complex.
    Tong JC; Tan TW; Ranganathan S
    Protein Sci; 2004 Sep; 13(9):2523-32. PubMed ID: 15322290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC-Peptide Tetramers to Visualize Antigen-Specific T Cells.
    Altman JD; Davis MM
    Curr Protoc Immunol; 2016 Nov; 115():17.3.1-17.3.44. PubMed ID: 27801510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemistry of peptides associated with MHC class I and class II molecules.
    Rammensee HG
    Curr Opin Immunol; 1995 Feb; 7(1):85-96. PubMed ID: 7772286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC-Fine: Fine-tuned AlphaFold for precise MHC-peptide complex prediction.
    Glukhov E; Kalitin D; Stepanenko D; Zhu Y; Nguyen T; Jones G; Patsahan T; Simmerling C; Mitchell JC; Vajda S; Dill KA; Padhorny D; Kozakov D
    Biophys J; 2024 Sep; 123(17):2902-2909. PubMed ID: 38751115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data.
    Reynisson B; Alvarez B; Paul S; Peters B; Nielsen M
    Nucleic Acids Res; 2020 Jul; 48(W1):W449-W454. PubMed ID: 32406916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets.
    Shao XM; Bhattacharya R; Huang J; Sivakumar IKA; Tokheim C; Zheng L; Hirsch D; Kaminow B; Omdahl A; Bonsack M; Riemer AB; Velculescu VE; Anagnostou V; Pagel KA; Karchin R
    Cancer Immunol Res; 2020 Mar; 8(3):396-408. PubMed ID: 31871119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide binding to major histocompatibility complex molecules.
    Barber LD; Parham P
    Annu Rev Cell Biol; 1993; 9():163-206. PubMed ID: 7506551
    [No Abstract]   [Full Text] [Related]  

  • 19. Structures of two classes of MHC molecules elucidated: crucial differences and similarities.
    Bjorkman PJ; Burmeister WP
    Curr Opin Struct Biol; 1994 Dec; 4(6):852-6. PubMed ID: 7712289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined prediction strategy increases identification of peptides bound with high affinity and stability to porcine MHC class I molecules SLA-1*04:01, SLA-2*04:01, and SLA-3*04:01.
    Pedersen LE; Rasmussen M; Harndahl M; Nielsen M; Buus S; Jungersen G
    Immunogenetics; 2016 Feb; 68(2):157-65. PubMed ID: 26572135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.